Matt Davidson insider trades

Open-market stock purchases and sales by Matt Davidson, Chief Development Officer at Adial Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 19, 2018.

Recent trades

DateStockTradeValue
Jun 12, 2026ADIL Adial Pharmaceuticals, IncBought (not open market)—
Jun 11, 2026ADIL Adial Pharmaceuticals, IncBought (not open market)—
Jun 11, 2026ADIL Adial Pharmaceuticals, IncBought (not open market)—
Jun 11, 2026ADIL Adial Pharmaceuticals, IncBought (not open market)—
Jun 11, 2026ADIL Adial Pharmaceuticals, IncBought (not open market)—

Companies traded

  • ADIL Adial Pharmaceuticals, Inc: other filings, last Jun 12, 2026
  • VRCA Verrica Pharmaceuticals Inc: 184 sales, last Sep 9, 2019

Get free alerts when Matt Davidson files a new trade →